Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry researchers · Thursday, March 28, 2024 · 699,407,154 Articles · 3+ Million Readers

Histamine H4 Receptor - Disease Assessment and Therapeutics Analysis Forecasts to 2024

PUNE, INDIA, March 20, 2018 /EINPresswire.com/ -- WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Histamine H4 Receptor - Pipeline Review, H1 2018”

Histamine H4 Receptor  

Overview

According to the recently published report 'Histamine H4 Receptor - Pipeline Review, H1 2018'; Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) pipeline Target constitutes close to 12 molecules. Out of which approximately 12 molecules are developed by Companies.

Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) - The histamine H4 receptor is a member of the G protein-coupled receptor super family.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3066582-histamine-h4-receptor-axor35-or-g-protein-coupled

Top Companies mentioned

Bioprojet SCR

Griffin Discoveries BV

Johnson & Johnson

Novartis AG

Palau Pharma SA

Sensorion SA

Histamine H4 Receptor Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Histamine H4 Receptor    - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Histamine H4 Receptor   , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 1, 7 and 1 respectively.

Histamine H4 Receptor pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Histamine H4 Receptor - Competitive Analysis

Key players are making innovative developments in Histamine H4 Receptor industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Histamine H4 Receptor.

The pipeline guide reviews pipeline therapeutics for Histamine H4 Receptor by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Histamine H4 Receptor therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Histamine H4 Receptor therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Histamine H4 Receptor.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3066582-histamine-h4-receptor-axor35-or-g-protein-coupled

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release